Globus Medical, Inc. (GMED) has a consensus analyst rating of Buy, based on 36 analysts covering the stock. Of those, 27 recommend buying, 8 recommend holding, and 1 recommend selling.
The analyst consensus price target for GMED is $104.00, representing a +9.5% upside from the current price of $94.94. Price targets range from a low of $64.00 to a high of $115.00.
